HAE: Summary for HAEMONETICS CP - Yahoo! Singapore Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 4:53pm SGT - The Singapore stock market closes in 7 minutes.

To create a watchlist or portfolio of shares, Register

FINANCE HOME PAGE

INVESTING

FINANCE NEWS

Haemonetics Corp. (HAE)

At 5:03AM SGT: 52.79 USD 0.00 (0.00%)

MORE ON HAE

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

HAEMONETICS CP (NYSE:HAE) Delayed quote data

Last Trade:	52.79 USD
Trade Time:	5:03AM SGT
Change:	0.00 (0.00%)
Prev Close:	52.79
Open:	N/A
Bid:	N/A
Ask:	N/A
1y Target Est:	66.50

Day's Range:	N/A - N/A
52wk Range:	46.78 - 63.75
Volume:	0
Avg Vol (3m):	186,356
Market Cap:	1.35B
P/E (ttm):	20.87
EPS (ttm):	2.53
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y max

Use Y! Toolbar to track stocks

Add HAE to Portfolio

Download Data

HEADLINES

•	HAEMONETICS CORP Financials
	EDGAR Online Financials (Wed 2:04am)

•	Award Winning Equity Analyst Sees 2010 Increase In Mergers And Acquisitions In Life Science Tools And Diagnostics Sector
	Wall Street Transcript (Wed, Feb 3)

•	Haemonetics Misses Zacks Estimate
	Zacks.com (Wed, Feb 3)

•	New Star Analyst Rankings for HAEMONETICS CP
	StarMine (Tue, Feb 2)

•	[$$] Pericom, PetroQuest, Kulicke & Soffa Jump
	at The Wall Street Journal Online (Tue, Feb 2)

•	Medical Devices Stock Review - Feb. 2010
	Zacks.com (Tue, Feb 2)

•	Haemonetics to buy Global Med Technologies in $60M deal
	at bizjournals.com (Tue, Feb 2)

•	Haemonetics shares dip on 3Q results; big purchase
	AP (Tue, Feb 2)

•	UPDATE - Haemonetics results misses view; to buy Global Med
	at Reuters (Mon, Feb 1)

•	HAEMONETICS CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
	EDGAR Online (Mon, Feb 1)

•	Haemonetics Reports Double Digit Growth in Earnings Per Share for Third Quarter Fiscal 2010
	PR Newswire (Mon, Feb 1)

•	Haemonetics Announces Definitive Agreement to Acquire Global Med Technologies, Inc.
	PR Newswire (Mon, Feb 1)

More Headlines for HAE...

ANALYST

EPS Est (next year) (Mar-10) :	2.82
EPS Est (in 2 years) (Mar-11) :	3.17
Avg Rec (current)*:	1.5
PEG Ratio:	1.37

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Haemonetics Corporation provides blood management solutions primarily in the United States, Europe, and Asia. The companys donor products and services include plasma systems that automate the collection of plasma from donors; blood bank syst...

Full Company Profile

Add to Portfolio

Email to a Friend

•